Article
06 May 2024
Biosimilar Approval Updates In Europe And China
DETAILS
United States
www.goodwinlaw.com
AUTHORS CONTENT
Articles
8
Article
26 Mar 2024
Celltrion Announces Commercial Availability Of ZYMFENTRA™ (Infliximab-dyyb)
Article
17 Jan 2024
Merck To Buy Harpoon Therapeutics For $680 Million
Article
18 Dec 2023
Regeneron Sues Formycon AG For Proposed Biosimilar Of EYLEA In West Virginia District Court
Article
09 Nov 2023
FDA Approves VABYSMO (Faricimab) For Retinal Vein Occlusion
Article
13 Sep 2023
Sandoz Receives FDA Approval For Tyruko® (Natalizumab-Sztn), The First And Only FDA-Approved Biosimilar For Relapsing Forms Of Multiple Sclerosis
Article
15 May 2023
Amgen Files BPCIA Complaint Against Sandoz Regarding Denosumab
Article
10 Mar 2023
Alkem Subsidiary Enzene Launches Adalimumab Biosimilar In India